Nutex Health Q1 Revenue Misses Estimates by 5%, Net Income Doubles
NUTX sits 58% above its 52-week low of $77.21.
Summary
Nutex Health reported mixed first-quarter results, with revenue rising 2.2% to $216.49 million but falling short of analyst estimates of $227.89 million. Despite the revenue miss, net income attributable to the company more than doubled year-over-year to $62.76 million. This mixed performance presents a nuanced picture for investors, as the top-line miss could temper enthusiasm despite strong bottom-line growth. Traders will be evaluating how the market weighs the revenue shortfall against the significant increase in profitability and the company's plans to open three new hospitals later in 2026.
At the time of this announcement, NUTX was trading at $121.80 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $830.6M. The 52-week trading range was $77.21 to $193.07. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.